在伊米基莫德诱导的牛皮中,LGR4缺乏会加剧皮肤炎症和表皮质增生
Mengfei Xue1, Ruijie Yang2, Guihong Li1
1Shanghai Fengxian District Central Hospital, School of Medicine, Anhui University of Science and Technology, Shanghai, China.
Immunology
|November 20, 2024
概括
这项研究表明,G蛋白结合受体LGR4 (Leucine丰富的重复含有G蛋白结合受体4) 有助于限制牛皮的进展. 在牛皮病变中较低的LGR4表达表明它.
科学领域:
- 皮肤病学和免疫学,专注于皮肤炎症和细胞过程.
背景情况:
- 牛皮是一种具有复杂机制的慢性炎症性皮肤疾病.
- 目前对牛皮病理学和有效治疗方法的理解仍然不完整.
研究的目的:
- 为了确定牛皮的新型治疗点.
- 研究G蛋白结合受体LGR4在牛皮进展中的作用.
主要方法:
- 从牛皮患者的临床数据的生物信息学分析.
- 使用HaCaT细胞进行体外研究.
- 在体内研究使用Lgr4-淘汰赛小鼠模型.
主要成果:
- 与健康皮肤相比,在牛皮病皮肤病变中观察到较低的LGR4表达.
- 在小鼠中Lgr4淘汰赛加剧了类似牛皮的症状,包括炎症增加和角质细胞增殖.
- LGR4 缺乏促进了炎症因子分泌和免疫细胞透.
结论:
- G蛋白结合受体LGR4在减轻牛皮进展方面发挥着关键作用.
- LGR4代表了治疗牛皮的潜在治疗标.
- 对LGR4调节的进一步研究可能会导致治疗牛皮的新临床策略.
相关概念视频
01:24T Cell Types and Functions
954
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
954
01:29Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
142
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
142